发明名称 Therapy via targeted delivery of nanoscale particles using L6 antibodies
摘要 Methods for treating cells, diseased tissue, pathogens, or other undesirable matter involve the administration of a bioprobe (energy susceptive materials that are attached to the target-specific ligand chimeric L6 antibody) to a patient's body, body part, tissue, or body fluid (such as blood, blood plasma, or blood serum). An energy source provides energy to the bioprobe so as to destroy, rupture, or inactivate the target. Various energy forms, such as AMF, microwave, acoustic, or a combination thereof, created via a variety of mechanisms, may be used. The disclosed methods may be useful in the treatment of a variety of indications, including but not limited to, cancer of any type, such as bone marrow, lung, vascular, neuro, colon, ovarian, breast and prostate cancer.
申请公布号 US2004156846(A1) 申请公布日期 2004.08.12
申请号 US20030360578 申请日期 2003.02.06
申请人 TRITON BIOSYSTEMS INC 发明人 DAUM WOLFGANG;DENARDO GERALD;ELLIS-BUSBY DIANE;FOREMAN ALAN;GWOST DOUGLAS U;HANDY ERIK SCHROEDER;IVKOV ROBERT
分类号 A61N2/00;A61N2/02;A61N5/02;C07K16/30;(IPC1-7):A61N1/30;A61K39/395 主分类号 A61N2/00
代理机构 代理人
主权项
地址